Btk inhibitor 2

CAS No. 1558036-85-3

Btk inhibitor 2( BGB-3111 analog )

Catalog No. M23674 CAS No. 1558036-85-3

Btk inhibitor 2 is a BTK inhibitor extracted from patent US 20170224688 A1 (BGB-3111 analog).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 40 In Stock
5MG 65 In Stock
10MG 95 In Stock
25MG 215 In Stock
50MG 356 In Stock
100MG 434 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Btk inhibitor 2
  • Note
    Research use only, not for human use.
  • Brief Description
    Btk inhibitor 2 is a BTK inhibitor extracted from patent US 20170224688 A1 (BGB-3111 analog).
  • Description
    Btk inhibitor 2 is a BTK inhibitor extracted from patent US 20170224688 A1 (BGB-3111 analog).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BGB-3111 analog
  • Pathway
    Tyrosine Kinase
  • Target
    BTK
  • Recptor
    BTK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1558036-85-3
  • Formula Weight
    431.49
  • Molecular Formula
    C24H25N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:75 mg/mL (173.82 mM; Need ultrasonic and warming)
  • SMILES
    C=CC(=O)N1CCC[C@H](C1)N2C(=C(C(=N2)C3=CC=C(C=C3)OC4=CC=CC=C4)C(=O)N)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cecile M. Krejsa. Methods of Using BTK Inhibitors to Treat Dermatoses. US 20170224688 A1.
molnova catalog
related products
  • PCI-32765 racemate

    A potent a+M7692nd highly selective Btk inhibitor with IC50 of 0.5 nM.

  • PRN 1008

    PRN1008 is a novel reversible, covalent and oral inhibitor of BTK with biochemical IC50 of 1.3 nM.

  • Larotinib

    Larotinib is an orally active, potent, and broad-spectrum tyrosine kinase inhibitor (TKI) with an IC50 of 0.6 nM for EGFR.